SlideShare a Scribd company logo
1 of 55
Dr Anand.M.Tiwari
F.N.B critical care medicine
Intensivist
Revision of the known facts
 What is the water content of human body?
 Male
 female
 50 to 60% of body weight
 Higher in neonates and children
 Lower in elderly
 Lower in women
 40% is intracellular.
 20% extracellular
 15% is interstitial
 5% is intravascular
28 L
14L
3.5 L
 Diffusion
 Facilitated diffusion
 Active transport
 Osmosis
 Osmolality
 Calculation
 2na+glu/18+
 bun/2.8
 Freezing point
depression method
 Hypotonic (cell
swells) 200mosm/litre
 Hypertonic cell shrink
–360 mosm/l
 Isotonic nochange
280mosm/l
Intracellular
Interstitial
Intravascular
2/3 1/3
3/4 1/4
Intracellular
Interstitial
Intravascular
2/3 1/3
3/4 1/4
ECF osmolality = ICF osmolality
K, ATP
Creatinine PO4
phospholipids
Na, Cl
HCO3
Intravascular
Interstitial
3/4 1/4
Capillary membrane
Plasma proteins
Intracellular
Interstitial
Intravascular
2/3 1/3
3/4 1/4
Na
K
Plasma
Na 153
IC K 150
Intracellular Interstitial
Intravascular
2/3 1/3
3/4 1/4
Intracellular
Interstitial Intravascular
2/3 1/3
3/4 1/4
Intracellular
Interstitial
Intravascular
2/3 1/3
666ml 250ml 84ml
Intracellular
Interstitial
Intravascular
2/3 1/3
750ml 250ml
Intracellular
Interstitial
Intravascular2/3 1/3
1000ml
Intracellular
Interstitial
Intravascular2/3 1/3
1000ml
 Intake and output must be balanced.
Intake---N fluid ingested—2100 +from
metabolism(200)=2300ml
output—urine-1400+feces(100)
-sweat-100
- insensible loses—skin-
350+lungs350ml
 Subject to variation environmental condition and
disease states
Weight Water requirement
0-10 kg 4mL/kg/hr
10-20 kg 40mL/hr +2ml/kg/hr for each kg>10kg
>20kg 60ml/hr +1ml/kg/hr for each
kg>20kg
for 60kg man this = 100ml/hr or 2400 ml/24 hrs
for normal people!!
Solutions Volumes Na+
K+
Ca2+
Mg2+
Cl- HCO3
-
Dextrose mOsm/L
ECF 142 4 5 103 27 280-310
Lactated
Ringer’
s
130 4 3 109 28 273
0.9% NaCl 154 154 308
0.45% NaCl 77 77 154
D5W 50 250
D5/0.45%
NaCl
77 77 50 406
3% NaCl 513 513 1026
6%
Hetasta
rch
500 154 154 310
5% Albumin 250,500
130
-
1
6
0
<2.5 130-160 330
25% Albumin 20,50,100
130
-
1 <2.5 130-160 330
 Crystalloids
relatively large volume
for resus
 Ideal for repleshing
third space loss
 Less fear of allergic
reaction
 Used as diluent for
ionotropic
adminstration
 Colloids
 Lesser volume better
expander more
duration
 Allergic reaction seen
as well interfearance
with blood
crossmatch
 R.L hartmen “solution,
balanced salt solution
 Isotonic -isobaric- iso-
osmolar- crystalloid
solution.
 Concentrations of ions—
Na-131mEq/l
calcium-2mEq/l
bicarbonate-29mEQ/L AS
LACTATE
K+ 5MeQ/L, CL- 110mEq/l
Ph-6.5,osmolarity-279
mosm/L
 Normal saline Isotonic
isobaric 0.9% w/vsolution
 Na+/cl- =154mEq/l Ph-5.0
0smolarity -308mosm/L
 --common maintainence
fluid till other are made
available
 ---in treatment of diabetic
ketoacidosis—2 litres
 --upper intestinal
obstruction and
hypochloremia
 RL-Solutions provides
electrolytes with lactate.
 Lactate is rapidly metabolized
in liver to bicarbonate helps in
correction of acidosis
 Mild to moderate hypovolemia
due to any cause
 As a maintainence fluid
 Preloading before spinal
anaesthesia
 Risk—Lactic acidosis
 hyperkalemia
 NS-Only fluid compatible with
blood.
 Flushing of dialysis set with
saline Surgeons use for –
washing crush injuries
peritoneal lavage
under water seal bottle
 Can be used as diluent for
medication
NS-RISK-Hyperchloraemic
metabolic acidosis more likely
with renal insufficiency
 FULFILLS INDICATIONS OF BOTH 5% DEX
AND .9% SALINE
 Useful particularly in pediatric patient
 Safely be used as maintainence fluid.
 Avoid for surgical procedures as dex best media
for bacterial growth
 Can be used along with blood
 It provides calories –each gm of glucose 4 kcal.
 --used to correct water deficit
 --used to correct hypoglycemia
 --used as carrier for giving drugs
dopamine,
aminophylline,noradrenaline,insulin,SNP
 Higher concentration is irritant to vien.
 Avoid extravasation
 Water intoxication,odema states
 Should not be given along with blood transfusion
 Avoid in known hyperglycemic as maintainence
fluid
 Hemaccel 3.5% poly gelatin
Na 145/cl 145 k-5.1, ca++-6.25mEq/l
 Mol wt 30,000 pH 7.3
 Half life 4-6hr
 Use in mod to severe shock.
 Priming solution
 Citrated blood should not be mixed.
 Produces histamine release/anaphylactic
 Dose should not increase 1000ml in 24 hrs.
 Careful in digitalized patient
 Avoid in hepatic renal and CCF
 However unlike other colloids does not cause
agglutination and Rolex formation
 6% SOLUTION mol wt-2,00,000da
 Dose 20ml/kg in 24 h
 These are hyperoncotic and cause intravascular
volume expansion
 Duration 12-24 hrs
 The incidence of anphylactoid reaction is low
 IT interferes PL Aggregation and coagulation.
 Thermo osmalarity-308mosm/l
 Ability to with draw fluid from interstital space in to
intravascular compartment
 It should be cautiously used in presence of renal
failure
 Dextran 40/ rheomacrodex
 --IT decreases viscosity of blood.
 --it improves micro circulation.
 --plasma half life 6-12hrs
 --dose 20 cc/kg/24hrs
 --it does not interfere with blood gp and
crossmatch
 Accumulation and tissue storage
 Effects on renal function
 Coagulopathy and bleeding risk
 Increase in amylase levels
 Anaphylactic potentials
 Cost factors
 New generation colloids-0.4 Molar
substitution==degradation factor
 hydroxyl ethyl group
 No risk of accumulation even with dosages increased
from 20ml/kg---50ml/kg
 No effects on renal and coagulopathy
 Quest for the new colloid--
 Balanced colloid solution like volulyte will end the debate
HES therapy
was associated
with higher
HES therapy was
associated with higher
rates of acute renal
failure and renal
-replacement therapy
than was
Ringer’s lactate.
N Engl J Med 2008;358:125-39.
Copyright © 2008 Massachusetts Medical Society
 What is the first sign of shock?
 a. Tachycardia
 b. hypotension
 c. narrow pulse pressure
 d. low urine output
paramet
er
class1 clqss2 class3 class4
%blood
vol/cns
<15%
anxious
15-30%
agitated
30-40%
confuse
>40%
lethargic
Pulse
rate
<100 >100 >120 >140
Supine
b.p
n n decrease decreas
Urine
output
>30ml/hr .20-30ml 5-15ml <5ml
Fluid resuscitation in uncontrolled
bleeding is deleterious
Delayed resuscitation is valid in trauma
systems with short response times
(<20 minutes to hospital from injury)
Attempts to control bleed should be given
greater importance
Fluids (pre-op) 2.4 L 0.4 L (p<0.001)
Survival 62% 70% (p=0.04)
ARDS/ renal failure 30% 23% (p=0.08)
Sepsis/ infection
Hospital days 14+24 11+19 (p=0.006)
N Engl J Med 1994;
331:1105-1109.
598 patients; penetrating torso injury
Field systolic BP <90 mm Hg (58+35)
309 289
Immediate fluids Delayed until induction
Trauma
Haemorrhage
Coagulation Hypotension
Fluid
Resuscitation
HaemorrhageHaemorrhage
Fluid
Resuscitation
Raises
BP
Dilutes
factors
 Restores volume +o2 carrying capacity
 Indicated in severe hemorrhagic shock eg pelvic
trauma ,variceal bleed
 Pre-operative measure
 Blood products for replenishing
coagulation/factors eg FFP, PL Conc,
 Pyrexial reaction,allergy
 Transmission of disease-syphilis ,viral
hepatitis,HIV,malaria
 Hemolytic reactions
 Citrate intoxication
 Hyperkalemia ,hypothermia
 Volume overload
 TRIM,TRALI
 PERIPHERIAL INTRACATH 16G
 Same gauze central line
 Hagen poiseuille equation rate @{radius} 4th
power
inversely proportional to length
 :;; infusion through central catheter will be as
much as 75% less than infusion rate through
peripheral cathter of equal diameter
 Fluid resuscitation may consist of natural or
artificial colloids or crystalloids
No evidenced-based support for one type
of fluid over another
•Crystalloids have a much larger volume of
distribution compared to colloids
•Crystalloid resuscitation requires more fluid to
achieve the same endpoints as colloid
•Crystalloids result in more edema
Choi PTL. Crit Care Med 1999;27:200-210.
Cook D. Ann Intern Med 2001;135:205-208.
Schierhout G. BMJ 1998;316:961-964.
Fluid Therapy: Choice of FluidFluid Therapy: Choice of Fluid
Grade C
Dellinger, et. al. Crit Care Med 2004, 32: 858-873.
 Fluid challenge in patients with suspected
hypovolemia may be given
500 - 1000 mL of crystalloids over 30 mins
300 - 500 mL of colloids over 30 mins
Repeat based on response and tolerance
Input is typically greater than output due to
venodilation and capillary leak
Most patients require continuing aggressive
fluid resuscitation during the first 24 hours of
management
Fluid Therapy: Fluid ChallengeFluid Therapy: Fluid Challenge
Grade E
Dellinger, et. al. Crit Care Med 2004, 32: 858-873.
 Central venous pressure (CVP) 8–12 mmHg
 – Mean arterial pressure (MAP) 65 mmHg
 – Urine output 0.5 ml/kg h1
 – Central venous (superior vena cava) or mixed
venous oxygen saturation 70%.
 Rationale. Early goal-directed therapy
(EGDT)
Intracellular
Interstitial
Intravascular
2/3 1/3
3/4 1/4
Na
 Blood Pressure—not a sensitive marker until
blood loss >30%
 NIBP-spuriously low measurement in patient with
hypovolemia (vasoconstrictor response)
 Direct IAP better ?
 Cardiac filling pressures
 CVP—limitation—Indirect measure
Change in CVP measured before
and 5 mins after bolus of fluid
◦0-3 mmHg: underfilled
◦3-5 mmHg: adequately filled
◦5-7 mmHg: overfilled
 1 a wave is due to atrial
contraction
 2.c wave due to buldging
of tricuspid valve in rt
atrium
 3 x descent depicts atrial
relaxation
 4 v due to rise in atrial
pressure before the
tricuspid valve opens
 5 y decent is due to atrial
emptying as blood enters
ventricles
Watch out for
Systolic pressure
variation
Fluid balance and therapy in critically ill

More Related Content

What's hot

isolyte and preperations
isolyte and preperationsisolyte and preperations
isolyte and preperationsNiranjanReddy39
 
IV Fluid Choice - An ICU Perspective
IV Fluid Choice - An ICU PerspectiveIV Fluid Choice - An ICU Perspective
IV Fluid Choice - An ICU PerspectiveSCGH ED CME
 
Fluid management & anesthesia
Fluid management & anesthesiaFluid management & anesthesia
Fluid management & anesthesiaSandro Zorzi
 
Static and dynamic indices of hemodynamic monitoring
Static and dynamic indices of hemodynamic monitoringStatic and dynamic indices of hemodynamic monitoring
Static and dynamic indices of hemodynamic monitoringBhargav Mundlapudi
 
VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?Sun Yai-Cheng
 
ECMO - extracorporeal membrane oxygenation
ECMO - extracorporeal membrane oxygenationECMO - extracorporeal membrane oxygenation
ECMO - extracorporeal membrane oxygenationprapulla chandra
 
Static and dynamic indices of hemodynamic monitoring
Static and dynamic indices of hemodynamic monitoringStatic and dynamic indices of hemodynamic monitoring
Static and dynamic indices of hemodynamic monitoringBhargav Mundlapudi
 
Predicting fluid response in the ICU
Predicting fluid response in the ICUPredicting fluid response in the ICU
Predicting fluid response in the ICUAndrew Ferguson
 
Fluid therapy
Fluid therapyFluid therapy
Fluid therapyghadimhmd
 
Pulmonary artery catheter
Pulmonary artery catheterPulmonary artery catheter
Pulmonary artery catheterArun Aru
 

What's hot (20)

Capnography
CapnographyCapnography
Capnography
 
Perioperative fluid therapy
Perioperative fluid therapyPerioperative fluid therapy
Perioperative fluid therapy
 
Fluid responsiveness in pratice
Fluid responsiveness in praticeFluid responsiveness in pratice
Fluid responsiveness in pratice
 
isolyte and preperations
isolyte and preperationsisolyte and preperations
isolyte and preperations
 
Ventilator Graphics
Ventilator GraphicsVentilator Graphics
Ventilator Graphics
 
IV Fluid Choice - An ICU Perspective
IV Fluid Choice - An ICU PerspectiveIV Fluid Choice - An ICU Perspective
IV Fluid Choice - An ICU Perspective
 
Fluid management & anesthesia
Fluid management & anesthesiaFluid management & anesthesia
Fluid management & anesthesia
 
Static and dynamic indices of hemodynamic monitoring
Static and dynamic indices of hemodynamic monitoringStatic and dynamic indices of hemodynamic monitoring
Static and dynamic indices of hemodynamic monitoring
 
Fluid therapy
Fluid therapyFluid therapy
Fluid therapy
 
VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?VBG or ABG analysis in Emergency Care?
VBG or ABG analysis in Emergency Care?
 
Iv fluids
Iv fluidsIv fluids
Iv fluids
 
ECMO - extracorporeal membrane oxygenation
ECMO - extracorporeal membrane oxygenationECMO - extracorporeal membrane oxygenation
ECMO - extracorporeal membrane oxygenation
 
Static and dynamic indices of hemodynamic monitoring
Static and dynamic indices of hemodynamic monitoringStatic and dynamic indices of hemodynamic monitoring
Static and dynamic indices of hemodynamic monitoring
 
Fluid therapy
Fluid therapyFluid therapy
Fluid therapy
 
Predicting fluid response in the ICU
Predicting fluid response in the ICUPredicting fluid response in the ICU
Predicting fluid response in the ICU
 
Fluid therapy
Fluid therapyFluid therapy
Fluid therapy
 
Sepsis update 2021
Sepsis update 2021Sepsis update 2021
Sepsis update 2021
 
Colloid vs Crystalloids
Colloid vs CrystalloidsColloid vs Crystalloids
Colloid vs Crystalloids
 
Pulmonary artery catheter
Pulmonary artery catheterPulmonary artery catheter
Pulmonary artery catheter
 
Basic mechanical ventilation settings
Basic mechanical ventilation settingsBasic mechanical ventilation settings
Basic mechanical ventilation settings
 

Viewers also liked

Emergency Fluid Therapy
Emergency Fluid TherapyEmergency Fluid Therapy
Emergency Fluid TherapyRashidi Ahmad
 
Holley: Transfusion and Coagulopathy
Holley: Transfusion and CoagulopathyHolley: Transfusion and Coagulopathy
Holley: Transfusion and CoagulopathySMACC Conference
 
John Myburgh: Fluid Resuscitation: Which, When and How Much?
John Myburgh: Fluid Resuscitation: Which, When and How Much?John Myburgh: Fluid Resuscitation: Which, When and How Much?
John Myburgh: Fluid Resuscitation: Which, When and How Much?SMACC Conference
 
Which fluid and when aagbi wsm
Which fluid and when aagbi wsmWhich fluid and when aagbi wsm
Which fluid and when aagbi wsmcraigmorris
 
Justin Bowra: IVC Filling: The Ultimate Myth
Justin Bowra: IVC Filling: The Ultimate MythJustin Bowra: IVC Filling: The Ultimate Myth
Justin Bowra: IVC Filling: The Ultimate MythSMACC Conference
 
Perioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and HaemostasisPerioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and HaemostasisAndrew Ferguson
 
Damage Control Resuscitation
Damage Control ResuscitationDamage Control Resuscitation
Damage Control ResuscitationSun Yai-Cheng
 
Fluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionFluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionAndrew Ferguson
 
coagulation system
coagulation systemcoagulation system
coagulation systemderosaMSKCC
 
Sharon Kay: Echo for Everyone: 5 Things Never to Miss
Sharon Kay: Echo for Everyone: 5 Things Never to MissSharon Kay: Echo for Everyone: 5 Things Never to Miss
Sharon Kay: Echo for Everyone: 5 Things Never to MissSMACC Conference
 
Intravenous fluids crystalloids and colloids
Intravenous fluids    crystalloids and colloidsIntravenous fluids    crystalloids and colloids
Intravenous fluids crystalloids and colloidsomar143
 
fluid optimization concept based on dynamic parameters of hemodynamic monitoring
fluid optimization concept based on dynamic parameters of hemodynamic monitoringfluid optimization concept based on dynamic parameters of hemodynamic monitoring
fluid optimization concept based on dynamic parameters of hemodynamic monitoringSurendra Patel
 

Viewers also liked (17)

Emergency Fluid Therapy
Emergency Fluid TherapyEmergency Fluid Therapy
Emergency Fluid Therapy
 
Holley: Transfusion and Coagulopathy
Holley: Transfusion and CoagulopathyHolley: Transfusion and Coagulopathy
Holley: Transfusion and Coagulopathy
 
John Myburgh: Fluid Resuscitation: Which, When and How Much?
John Myburgh: Fluid Resuscitation: Which, When and How Much?John Myburgh: Fluid Resuscitation: Which, When and How Much?
John Myburgh: Fluid Resuscitation: Which, When and How Much?
 
Which fluid and when aagbi wsm
Which fluid and when aagbi wsmWhich fluid and when aagbi wsm
Which fluid and when aagbi wsm
 
Justin Bowra: IVC Filling: The Ultimate Myth
Justin Bowra: IVC Filling: The Ultimate MythJustin Bowra: IVC Filling: The Ultimate Myth
Justin Bowra: IVC Filling: The Ultimate Myth
 
Perioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and HaemostasisPerioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and Haemostasis
 
Hemodynamic
HemodynamicHemodynamic
Hemodynamic
 
Damage Control Resuscitation
Damage Control ResuscitationDamage Control Resuscitation
Damage Control Resuscitation
 
Fluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionFluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive Transfusion
 
Damage Control Resuscitation
Damage  Control  ResuscitationDamage  Control  Resuscitation
Damage Control Resuscitation
 
coagulation system
coagulation systemcoagulation system
coagulation system
 
Sharon Kay: Echo for Everyone: 5 Things Never to Miss
Sharon Kay: Echo for Everyone: 5 Things Never to MissSharon Kay: Echo for Everyone: 5 Things Never to Miss
Sharon Kay: Echo for Everyone: 5 Things Never to Miss
 
Surgery 6th year, Tutorial (Dr. Aram Baram)
Surgery 6th year, Tutorial (Dr. Aram Baram)Surgery 6th year, Tutorial (Dr. Aram Baram)
Surgery 6th year, Tutorial (Dr. Aram Baram)
 
Hemostasis
HemostasisHemostasis
Hemostasis
 
Intravenous fluids crystalloids and colloids
Intravenous fluids    crystalloids and colloidsIntravenous fluids    crystalloids and colloids
Intravenous fluids crystalloids and colloids
 
shock
shockshock
shock
 
fluid optimization concept based on dynamic parameters of hemodynamic monitoring
fluid optimization concept based on dynamic parameters of hemodynamic monitoringfluid optimization concept based on dynamic parameters of hemodynamic monitoring
fluid optimization concept based on dynamic parameters of hemodynamic monitoring
 

Similar to Fluid balance and therapy in critically ill

Hypotension management in ICU, volume vessel or pump?
Hypotension  management in ICU, volume vessel or pump?Hypotension  management in ICU, volume vessel or pump?
Hypotension management in ICU, volume vessel or pump?intentdoc
 
Fluid manage 최종[1]
Fluid manage 최종[1]Fluid manage 최종[1]
Fluid manage 최종[1]Seungyoun Kang
 
Fluids
Fluids		Fluids
Fluids Khalid
 
Fluids & Electrolytes
Fluids & ElectrolytesFluids & Electrolytes
Fluids & Electrolytesekhlashosny
 
Fluids &amp; Electrolytes
Fluids &amp; ElectrolytesFluids &amp; Electrolytes
Fluids &amp; Electrolytesekhlashosny
 
Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020EmanElrefaie
 
Dialysis prescription 2
Dialysis prescription 2Dialysis prescription 2
Dialysis prescription 2Chioma Iheme
 
Update on fluid therapy in dhf
Update on fluid therapy in dhfUpdate on fluid therapy in dhf
Update on fluid therapy in dhfDr Iyan Darmawan
 
Concept of I/V fluid & its updates on surgical practice
Concept of I/V fluid & its updates on surgical practiceConcept of I/V fluid & its updates on surgical practice
Concept of I/V fluid & its updates on surgical practiceDr. MD. Majedul Islam
 
classification,recognition and management of shock
classification,recognition and management of shockclassification,recognition and management of shock
classification,recognition and management of shockDr. Shahnawaz Alam
 
Shock in a Trauma patient - a maxillofacial perspective
Shock in a Trauma patient - a maxillofacial perspectiveShock in a Trauma patient - a maxillofacial perspective
Shock in a Trauma patient - a maxillofacial perspectiveKeerthana Ashok
 

Similar to Fluid balance and therapy in critically ill (20)

Hypotension management in ICU, volume vessel or pump?
Hypotension  management in ICU, volume vessel or pump?Hypotension  management in ICU, volume vessel or pump?
Hypotension management in ICU, volume vessel or pump?
 
Fluid manage 최종[1]
Fluid manage 최종[1]Fluid manage 최종[1]
Fluid manage 최종[1]
 
Perioperative fluid management
Perioperative fluid managementPerioperative fluid management
Perioperative fluid management
 
Fluids
Fluids		Fluids
Fluids
 
Shock
ShockShock
Shock
 
Fluids & Electrolytes
Fluids & ElectrolytesFluids & Electrolytes
Fluids & Electrolytes
 
Fluids &amp; Electrolytes
Fluids &amp; ElectrolytesFluids &amp; Electrolytes
Fluids &amp; Electrolytes
 
Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020Critical care nephrology 26 6-2020
Critical care nephrology 26 6-2020
 
Dialysis prescription 2
Dialysis prescription 2Dialysis prescription 2
Dialysis prescription 2
 
Sepsis nuts&bolts
Sepsis nuts&boltsSepsis nuts&bolts
Sepsis nuts&bolts
 
intravenous fluid
intravenous fluidintravenous fluid
intravenous fluid
 
Update on fluid therapy in dhf
Update on fluid therapy in dhfUpdate on fluid therapy in dhf
Update on fluid therapy in dhf
 
Concept of I/V fluid & its updates on surgical practice
Concept of I/V fluid & its updates on surgical practiceConcept of I/V fluid & its updates on surgical practice
Concept of I/V fluid & its updates on surgical practice
 
classification,recognition and management of shock
classification,recognition and management of shockclassification,recognition and management of shock
classification,recognition and management of shock
 
AKI in pediatric
AKI in pediatric AKI in pediatric
AKI in pediatric
 
Fluid therapy in stroke
Fluid therapy in strokeFluid therapy in stroke
Fluid therapy in stroke
 
Fluid sepsis ny_2013a
Fluid sepsis ny_2013aFluid sepsis ny_2013a
Fluid sepsis ny_2013a
 
word 2.pptx
word 2.pptxword 2.pptx
word 2.pptx
 
Blood Transfusion
Blood TransfusionBlood Transfusion
Blood Transfusion
 
Shock in a Trauma patient - a maxillofacial perspective
Shock in a Trauma patient - a maxillofacial perspectiveShock in a Trauma patient - a maxillofacial perspective
Shock in a Trauma patient - a maxillofacial perspective
 

More from Anand Tiwari

Update on cardiac arrrest and post cardiac arrest management16 1-18
Update on cardiac arrrest and post cardiac arrest management16 1-18Update on cardiac arrrest and post cardiac arrest management16 1-18
Update on cardiac arrrest and post cardiac arrest management16 1-18Anand Tiwari
 
Emergency management in office practice
Emergency management in office practiceEmergency management in office practice
Emergency management in office practiceAnand Tiwari
 
22 09-12 how do i ventilate normal lung
22 09-12 how do i ventilate normal lung22 09-12 how do i ventilate normal lung
22 09-12 how do i ventilate normal lungAnand Tiwari
 
Review course 2013 answer key.anand.tiwari
Review course 2013 answer key.anand.tiwariReview course 2013 answer key.anand.tiwari
Review course 2013 answer key.anand.tiwariAnand Tiwari
 
Poster presentation
Poster presentationPoster presentation
Poster presentationAnand Tiwari
 
Glucose homeostasis
Glucose homeostasisGlucose homeostasis
Glucose homeostasisAnand Tiwari
 
Ecg Interpritation (2)
Ecg Interpritation (2)Ecg Interpritation (2)
Ecg Interpritation (2)Anand Tiwari
 

More from Anand Tiwari (8)

Update on cardiac arrrest and post cardiac arrest management16 1-18
Update on cardiac arrrest and post cardiac arrest management16 1-18Update on cardiac arrrest and post cardiac arrest management16 1-18
Update on cardiac arrrest and post cardiac arrest management16 1-18
 
Emergency management in office practice
Emergency management in office practiceEmergency management in office practice
Emergency management in office practice
 
22 09-12 how do i ventilate normal lung
22 09-12 how do i ventilate normal lung22 09-12 how do i ventilate normal lung
22 09-12 how do i ventilate normal lung
 
Review course 2013 answer key.anand.tiwari
Review course 2013 answer key.anand.tiwariReview course 2013 answer key.anand.tiwari
Review course 2013 answer key.anand.tiwari
 
Abg skill station
Abg skill stationAbg skill station
Abg skill station
 
Poster presentation
Poster presentationPoster presentation
Poster presentation
 
Glucose homeostasis
Glucose homeostasisGlucose homeostasis
Glucose homeostasis
 
Ecg Interpritation (2)
Ecg Interpritation (2)Ecg Interpritation (2)
Ecg Interpritation (2)
 

Recently uploaded

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 

Recently uploaded (20)

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 

Fluid balance and therapy in critically ill

  • 1. Dr Anand.M.Tiwari F.N.B critical care medicine Intensivist
  • 2. Revision of the known facts
  • 3.  What is the water content of human body?  Male  female
  • 4.  50 to 60% of body weight  Higher in neonates and children  Lower in elderly  Lower in women
  • 5.
  • 6.
  • 7.  40% is intracellular.  20% extracellular  15% is interstitial  5% is intravascular 28 L 14L 3.5 L
  • 8.  Diffusion  Facilitated diffusion  Active transport  Osmosis  Osmolality  Calculation  2na+glu/18+  bun/2.8  Freezing point depression method
  • 9.  Hypotonic (cell swells) 200mosm/litre  Hypertonic cell shrink –360 mosm/l  Isotonic nochange 280mosm/l
  • 11. Intracellular Interstitial Intravascular 2/3 1/3 3/4 1/4 ECF osmolality = ICF osmolality K, ATP Creatinine PO4 phospholipids Na, Cl HCO3
  • 20.  Intake and output must be balanced. Intake---N fluid ingested—2100 +from metabolism(200)=2300ml output—urine-1400+feces(100) -sweat-100 - insensible loses—skin- 350+lungs350ml  Subject to variation environmental condition and disease states
  • 21. Weight Water requirement 0-10 kg 4mL/kg/hr 10-20 kg 40mL/hr +2ml/kg/hr for each kg>10kg >20kg 60ml/hr +1ml/kg/hr for each kg>20kg for 60kg man this = 100ml/hr or 2400 ml/24 hrs for normal people!!
  • 22. Solutions Volumes Na+ K+ Ca2+ Mg2+ Cl- HCO3 - Dextrose mOsm/L ECF 142 4 5 103 27 280-310 Lactated Ringer’ s 130 4 3 109 28 273 0.9% NaCl 154 154 308 0.45% NaCl 77 77 154 D5W 50 250 D5/0.45% NaCl 77 77 50 406 3% NaCl 513 513 1026 6% Hetasta rch 500 154 154 310 5% Albumin 250,500 130 - 1 6 0 <2.5 130-160 330 25% Albumin 20,50,100 130 - 1 <2.5 130-160 330
  • 23.
  • 24.  Crystalloids relatively large volume for resus  Ideal for repleshing third space loss  Less fear of allergic reaction  Used as diluent for ionotropic adminstration  Colloids  Lesser volume better expander more duration  Allergic reaction seen as well interfearance with blood crossmatch
  • 25.  R.L hartmen “solution, balanced salt solution  Isotonic -isobaric- iso- osmolar- crystalloid solution.  Concentrations of ions— Na-131mEq/l calcium-2mEq/l bicarbonate-29mEQ/L AS LACTATE K+ 5MeQ/L, CL- 110mEq/l Ph-6.5,osmolarity-279 mosm/L  Normal saline Isotonic isobaric 0.9% w/vsolution  Na+/cl- =154mEq/l Ph-5.0 0smolarity -308mosm/L  --common maintainence fluid till other are made available  ---in treatment of diabetic ketoacidosis—2 litres  --upper intestinal obstruction and hypochloremia
  • 26.  RL-Solutions provides electrolytes with lactate.  Lactate is rapidly metabolized in liver to bicarbonate helps in correction of acidosis  Mild to moderate hypovolemia due to any cause  As a maintainence fluid  Preloading before spinal anaesthesia  Risk—Lactic acidosis  hyperkalemia  NS-Only fluid compatible with blood.  Flushing of dialysis set with saline Surgeons use for – washing crush injuries peritoneal lavage under water seal bottle  Can be used as diluent for medication NS-RISK-Hyperchloraemic metabolic acidosis more likely with renal insufficiency
  • 27.  FULFILLS INDICATIONS OF BOTH 5% DEX AND .9% SALINE  Useful particularly in pediatric patient  Safely be used as maintainence fluid.  Avoid for surgical procedures as dex best media for bacterial growth  Can be used along with blood
  • 28.  It provides calories –each gm of glucose 4 kcal.  --used to correct water deficit  --used to correct hypoglycemia  --used as carrier for giving drugs dopamine, aminophylline,noradrenaline,insulin,SNP
  • 29.  Higher concentration is irritant to vien.  Avoid extravasation  Water intoxication,odema states  Should not be given along with blood transfusion  Avoid in known hyperglycemic as maintainence fluid
  • 30.  Hemaccel 3.5% poly gelatin Na 145/cl 145 k-5.1, ca++-6.25mEq/l  Mol wt 30,000 pH 7.3  Half life 4-6hr  Use in mod to severe shock.  Priming solution
  • 31.  Citrated blood should not be mixed.  Produces histamine release/anaphylactic  Dose should not increase 1000ml in 24 hrs.  Careful in digitalized patient  Avoid in hepatic renal and CCF  However unlike other colloids does not cause agglutination and Rolex formation
  • 32.  6% SOLUTION mol wt-2,00,000da  Dose 20ml/kg in 24 h  These are hyperoncotic and cause intravascular volume expansion  Duration 12-24 hrs  The incidence of anphylactoid reaction is low
  • 33.  IT interferes PL Aggregation and coagulation.  Thermo osmalarity-308mosm/l  Ability to with draw fluid from interstital space in to intravascular compartment  It should be cautiously used in presence of renal failure
  • 34.  Dextran 40/ rheomacrodex  --IT decreases viscosity of blood.  --it improves micro circulation.  --plasma half life 6-12hrs  --dose 20 cc/kg/24hrs  --it does not interfere with blood gp and crossmatch
  • 35.  Accumulation and tissue storage  Effects on renal function  Coagulopathy and bleeding risk  Increase in amylase levels  Anaphylactic potentials  Cost factors
  • 36.  New generation colloids-0.4 Molar substitution==degradation factor  hydroxyl ethyl group  No risk of accumulation even with dosages increased from 20ml/kg---50ml/kg  No effects on renal and coagulopathy  Quest for the new colloid--  Balanced colloid solution like volulyte will end the debate
  • 37. HES therapy was associated with higher HES therapy was associated with higher rates of acute renal failure and renal -replacement therapy than was Ringer’s lactate. N Engl J Med 2008;358:125-39. Copyright © 2008 Massachusetts Medical Society
  • 38.
  • 39.  What is the first sign of shock?  a. Tachycardia  b. hypotension  c. narrow pulse pressure  d. low urine output
  • 40. paramet er class1 clqss2 class3 class4 %blood vol/cns <15% anxious 15-30% agitated 30-40% confuse >40% lethargic Pulse rate <100 >100 >120 >140 Supine b.p n n decrease decreas Urine output >30ml/hr .20-30ml 5-15ml <5ml
  • 41. Fluid resuscitation in uncontrolled bleeding is deleterious Delayed resuscitation is valid in trauma systems with short response times (<20 minutes to hospital from injury) Attempts to control bleed should be given greater importance
  • 42. Fluids (pre-op) 2.4 L 0.4 L (p<0.001) Survival 62% 70% (p=0.04) ARDS/ renal failure 30% 23% (p=0.08) Sepsis/ infection Hospital days 14+24 11+19 (p=0.006) N Engl J Med 1994; 331:1105-1109. 598 patients; penetrating torso injury Field systolic BP <90 mm Hg (58+35) 309 289 Immediate fluids Delayed until induction
  • 44.  Restores volume +o2 carrying capacity  Indicated in severe hemorrhagic shock eg pelvic trauma ,variceal bleed  Pre-operative measure  Blood products for replenishing coagulation/factors eg FFP, PL Conc,
  • 45.  Pyrexial reaction,allergy  Transmission of disease-syphilis ,viral hepatitis,HIV,malaria  Hemolytic reactions  Citrate intoxication  Hyperkalemia ,hypothermia  Volume overload  TRIM,TRALI
  • 46.  PERIPHERIAL INTRACATH 16G  Same gauze central line  Hagen poiseuille equation rate @{radius} 4th power inversely proportional to length  :;; infusion through central catheter will be as much as 75% less than infusion rate through peripheral cathter of equal diameter
  • 47.  Fluid resuscitation may consist of natural or artificial colloids or crystalloids No evidenced-based support for one type of fluid over another •Crystalloids have a much larger volume of distribution compared to colloids •Crystalloid resuscitation requires more fluid to achieve the same endpoints as colloid •Crystalloids result in more edema Choi PTL. Crit Care Med 1999;27:200-210. Cook D. Ann Intern Med 2001;135:205-208. Schierhout G. BMJ 1998;316:961-964. Fluid Therapy: Choice of FluidFluid Therapy: Choice of Fluid Grade C Dellinger, et. al. Crit Care Med 2004, 32: 858-873.
  • 48.  Fluid challenge in patients with suspected hypovolemia may be given 500 - 1000 mL of crystalloids over 30 mins 300 - 500 mL of colloids over 30 mins Repeat based on response and tolerance Input is typically greater than output due to venodilation and capillary leak Most patients require continuing aggressive fluid resuscitation during the first 24 hours of management Fluid Therapy: Fluid ChallengeFluid Therapy: Fluid Challenge Grade E Dellinger, et. al. Crit Care Med 2004, 32: 858-873.
  • 49.  Central venous pressure (CVP) 8–12 mmHg  – Mean arterial pressure (MAP) 65 mmHg  – Urine output 0.5 ml/kg h1  – Central venous (superior vena cava) or mixed venous oxygen saturation 70%.  Rationale. Early goal-directed therapy (EGDT)
  • 51.  Blood Pressure—not a sensitive marker until blood loss >30%  NIBP-spuriously low measurement in patient with hypovolemia (vasoconstrictor response)  Direct IAP better ?  Cardiac filling pressures  CVP—limitation—Indirect measure
  • 52. Change in CVP measured before and 5 mins after bolus of fluid ◦0-3 mmHg: underfilled ◦3-5 mmHg: adequately filled ◦5-7 mmHg: overfilled
  • 53.  1 a wave is due to atrial contraction  2.c wave due to buldging of tricuspid valve in rt atrium  3 x descent depicts atrial relaxation  4 v due to rise in atrial pressure before the tricuspid valve opens  5 y decent is due to atrial emptying as blood enters ventricles
  • 54. Watch out for Systolic pressure variation

Editor's Notes

  1. No evidence-based support for one type of crystalloid over another No studies that are specific to sepsis population Note: since development of these guidelines the preliminary results of the SAFE (Fluid resuscitation with Albumin vs. Saline) study results have been reported at the Society of Critical Care Medicine National Scientific Meeting held in Feb. 2004. This randomized controlled trial of over 7,000 patients demonstrated that in the subset of severe sepsis patients there was a mortality benefit with albumin over saline (RR .087; CI 0.74-1.02). This data set was locked in late 2003; therefore, final manuscript publication is pending.
  2. Fluid Challenge describes the initial volume expansion period in which the patient’s response is closely monitored. Fluid Challenge must be clearly separated from an increase in maintenance fluid administration Response may be measured by increase in blood pressure and urine output Tolerance may be measured by evidence of intravascular volume overload Input/output ratio is of no utility to judge fluid resuscitation during this time period